Clinical Trials Browser

Phase 1 × NSCLC × osimertinib × Clear all

NCT06362980 2024-07-10

EGFR

Phase 1 Recruiting

NSCLC

NCT05693090 2023-03-06

Tipifarnib and Osimertinib in EGFR-mutated Non-Small Cell Lung Cancer

Phase 1 Withdrawn

NSCLC